Quarterly report pursuant to Section 13 or 15(d)

Accrued Expenses And Other Current Liabilities (Details)

v3.19.3
Accrued Expenses And Other Current Liabilities (Details) - USD ($)
Sep. 30, 2019
Dec. 31, 2018
Accrued Liabilities and Other Liabilities [Abstract]    
Sales returns and allowances $ 5,143,150 $ 3,972,510
Medicaid rebates 2,603,632 2,237,269
Minimum sales commitments, royalties payable, and purchase obligations 957,243 9,662,901
Compensation and benefits 1,993,211 1,953,065
Research and development expenses 1,409,738 278,132
Sales and marketing 125,494 1,112,378
General and administrative 775,163 235,721
Other 126,264 279,397
Total accrued expenses and other current liabilities $ 13,133,895 $ 19,731,373